Aspire Biopharma Holdings Statistics
Total Valuation
ASBP has a market cap or net worth of $13.91 million. The enterprise value is $19.33 million.
| Market Cap | 13.91M |
| Enterprise Value | 19.33M |
Important Dates
The next estimated earnings date is Sunday, August 24, 2025, before market open.
| Earnings Date | Aug 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ASBP has 48.90 million shares outstanding. The number of shares has increased by 77.18% in one year.
| Current Share Class | 48.90M |
| Shares Outstanding | 48.90M |
| Shares Change (YoY) | +77.18% |
| Shares Change (QoQ) | -91.39% |
| Owned by Insiders (%) | 23.17% |
| Owned by Institutions (%) | 6.38% |
| Float | 34.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.22
| Current Ratio | 0.22 |
| Quick Ratio | 0.15 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.20 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 34.84% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ASBP has paid $1,013 in taxes.
| Income Tax | 1,013 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.48% in the last 52 weeks. The beta is 0.91, so ASBP's price volatility has been similar to the market average.
| Beta (5Y) | 0.91 |
| 52-Week Price Change | -97.48% |
| 50-Day Moving Average | 0.37 |
| 200-Day Moving Average | 6.71 |
| Relative Strength Index (RSI) | 42.47 |
| Average Volume (20 Days) | 4,296,236 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.41M |
| Pretax Income | n/a |
| Net Income | -17.02M |
| EBITDA | n/a |
| EBIT | -2.41M |
| Earnings Per Share (EPS) | -$0.35 |
Balance Sheet
The company has $1.35 million in cash and $6.76 million in debt, giving a net cash position of -$5.42 million or -$0.11 per share.
| Cash & Cash Equivalents | 1.35M |
| Total Debt | 6.76M |
| Net Cash | -5.42M |
| Net Cash Per Share | -$0.11 |
| Equity (Book Value) | -6.95M |
| Book Value Per Share | -0.14 |
| Working Capital | -6.90M |
Cash Flow
| Operating Cash Flow | -1.82M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASBP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -77.18% |
| Shareholder Yield | -77.18% |
| Earnings Yield | -122.34% |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |